DePuy wins FDA supplemental approval for ceramic hip implant

April 26, 2013 by Arezu Sarvestani

Johnson & Johnson subsidiary DePuy Orthopaedics won supplemental FDA approval for a new size of its Ceramax ceramic-on-ceramic artificial hip replacement system.

DePuy's Ceramax hip implant

The FDA this month granted supplemental approval to Johnson & Johnson (NYSE:JNJ) and its DePuy Orthopaedics subsidiary for a new size of the Ceramax ceramic-on-ceramic hip implant.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp